RecruitingPhase 1NCT07103018
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Sponsor: K36 Therapeutics, Inc.
Miami, FL · Port Saint Lucie, FL · +11 more sites
Prostate Cancer clinical trials in Miami, FL
28 recruiting prostate cancer studies with a site in Miami, FL.
RecruitingPhase 3NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Sponsor: AstraZeneca
Miami, FL · +27 more sites
RecruitingPhase 1NCT06879041
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: AstraZeneca
Miami, FL · Tampa, FL · +10 more sites
RecruitingPhase 1 / Phase 2NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Sponsor: ModeX Therapeutics, An OPKO Health Company
Miami, FL · +5 more sites
RecruitingPhase 1 / Phase 2NCT07590934
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Miami, FL · Orlando, FL · Tampa, FL · +9 more sites
RecruitingNot applicableNCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Sponsor: Axonics, Inc.
Miami, FL · Orlando, FL · Oxford, FL · +20 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Aventura, FL · Coral Gables, FL · Deerfield Beach, FL · +331 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Miami, FL · Tampa, FL · +14 more sites
RecruitingPhase 1 / Phase 2NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Sponsor: PMV Pharmaceuticals, Inc
Miami, FL · Orlando, FL · Port Charlotte, FL · +29 more sites
RecruitingPhase 1NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Sponsor: Exelixis
Celebration, FL · Gainesville, FL · Jacksonville, FL · +43 more sites
RecruitingNot applicableNCT06534918
Precise Oncology Interventions in Nutrition and Training (OnPoint)
Sponsor: University of Miami
Miami, FL
RecruitingPhase 2 / Phase 3NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Sponsor: Novartis Pharmaceuticals
Miami, FL · Orlando, FL · +33 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
Miami, FL · Orlando, FL · Port Saint Lucie, FL · +19 more sites
RecruitingPhase 1NCT07581184
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Aktis Oncology, Inc.
Miami, FL · +5 more sites
RecruitingPhase 3NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Sponsor: Clarity Pharmaceuticals Ltd
Jacksonville, FL · Miami, FL · +27 more sites
RecruitingPhase 1 / Phase 2NCT06785636
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Sponsor: Pathos AI, Inc.
Miami, FL · +18 more sites
RecruitingPhase 2NCT06842498
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sponsor: Kyntra Bio
Aventura, FL · Hialeah, FL · Miami, FL · +20 more sites
RecruitingPhase 2NCT07455903
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Sponsor: Baptist Health South Florida
Miami, FL
RecruitingPhase 3NCT07052214
PSMA PET Combined With MRI for the Detection of PCa
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Boca Raton, FL · Miami, FL · +14 more sites
RecruitingPhase 3NCT06520345
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Miami, FL · +8 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Aventura, FL · Coral Gables, FL · Coral Springs, FL · +371 more sites
RecruitingPhase 2NCT06392295
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
Sponsor: University of Miami
Miami, FL
RecruitingPhase 1 / Phase 2NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Sponsor: Blue Earth Therapeutics Ltd
Miami, FL · +3 more sites
RecruitingNot applicableNCT06487507
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
Sponsor: University of Miami
Miami, FL
RecruitingPhase not listedNCT02997709
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
Sponsor: University of Miami
Miami, FL
RecruitingPhase 2NCT06111313
The University of Miami Adapt (UAdapt) Trial
Sponsor: University of Miami
Miami, FL
RecruitingPhase 1NCT06778863
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Sponsor: Clasp Therapeutics, Inc.
Miami, FL · +20 more sites
Not yet recruitingPhase 4NCT07278362
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Sponsor: University of Miami
Miami, FL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.